Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 3,834 | 6,377 | 4,947 | 19,244 | 12,494 |
| Cost of Goods | 2,003 | 3,530 | 3,124 | 3,002 | 2,035 |
| Gross Profit | 1,831 | 2,847 | 1,822 | 16,242 | 10,460 |
| Operating Expenses | 3,108 | -244 | 2,542 | 3,040 | 3,795 |
| Operating Income | -1,274 | 3,620 | -595 | 13,204 | 6,700 |
| Interest Expense | 0 | 0 | 4 | 4 | 4 |
| Other Income | 6,232 | -4,636 | 5,049 | 5,116 | -7,880 |
| Pre-tax Income | 4,957 | -1,016 | 4,450 | 18,316 | -1,184 |
| Income Tax | 3 | 2 | 33 | 2 | 3 |
| Net Income Continuous | 4,954 | -1,017 | 4,417 | 18,314 | -1,187 |
| Net Income | $4,954 | $-1,017 | $4,417 | $18,314 | $-1,187 |
| EPS Basic Total Ops | 0.48 | -0.10 | 0.40 | 1.68 | -0.08 |
| EPS Basic Continuous Ops | 0.45 | -0.07 | 0.40 | 1.68 | -0.11 |
| EPS Diluted Total Ops | -0.08 | 0.61 | -0.08 | 1.28 | -0.08 |
| EPS Diluted Continuous Ops | 0.45 | -0.04 | 0.40 | 1.53 | -0.11 |
| EBITDA(a) | $-1,270 | $3,667 | $-561 | $13,244 | $6,746 |